The Left Atrial Appendage (LAA) closure is a crucial procedure to reduce the risk of thromboembolism in patients with non-valvular atrial fibrillation. Boston Scientific Watchman FLX device is particularly beneficial for patients who are at an increased risk for stroke and systemic embolism, as identified by CHA2DS2-VASc scores. It's especially valuable for those who are…
Another great left atrial appendage closure procedure at Zala County Hospital. Congratulations to Dr. Tamás TAHIN and Team for the nice results!
#LAAC #Watchman #BostonScientific #medicaldevice #healthcareinnovation #deliveringhealthcaresolutions #DHSHungary
Nicely positioned Boston Scientific Watchman™ FLX device at Military Hospital. Congratulations to Dr. Gábor DURAY, Dr. Balázs POLGÁR and Team for the case!
#LAAC #Watchman #BostonScientific #medicaldevice #healthcareinnovation #deliveringhealthcaresolutions #DHSHungary
Another great left atrial appendage closure procedure at Military Hospital from last week. Congratulations to Dr. Gábor DURAY, Dr. Balázs POLGÁR and Team for the nice results! #LAAC #Watchman #BostonScientific #medicaldevice #healthcareinnovation #deliveringhealthcaresolutions #DHSHungary
Great #LAAC cases at Zala County Hospital with Dr. Tamás TAHIN and Team.
Recently WATCHMAN FLX Device received FDA approvalfor DAPT labeling. With the approval of immediate DAPT-use post-implant, only the WATCHMAN FLX™ Implant provides you with flexibility to choose the ideal drug regimen that is best for your patient with clinical outcomes that support…
Watchman™ FLX implantation at Semmelweis University by Prof. Dr. László GELLÉR, Dr. Zoltán SALLÓ and Dr. Anikó NAGY. Watchman FLX has a robust clinical evidence background: The SURPASS analysis of the NCDR-LAAO Registry™ has data of 16.000+ patients to date and confirms the best-in-class safety profile of Watchman FLX.
#dailywork #LAAC #Watchman #BostonScientific #medicaldevice…
Dr. Zoltán RUZSA and Dr. Zoltán JAMBRIK are performing WatchmanFLX cases in Szeged with the professional support of Prof. Dr. László GELLÉR. Congratulations for the GREAT WORK! The WatchmanFLX device platform is the most studied LAA occluder in the world with proven great performance and very low complication rates.
#LAAC #WatchmanFLX #BostonScientific #medicaldevice #healthcareinnovation #DeliveringHealthcareSolutions…
Left atrial appendage closure with Watchman™ FLX device at Semmelweis Heart and Vascular Center. Implanter: Prof.Dr.László GELLÉR, echocardiographer: Dr. Anikó NAGY. Congratulations for the great work! The WatchmanFLX device platform is the most studied #LAA occluder in the world with proven great performance and very low complication rates.
Watchman FLX has a robust clinical evidence…
Prof. Dr. László GELLÉR and Team performed 4 left atrial appendage closure procedures at Semmelweis University Heart and Vascular Center with Boston Scientific Watchman™ FLX device. Great achievement!
#LAAC #Watchman #BostonScientific #medicaldevice #healthcareinnovation #deliveringhealthcaresolutions #DHSHungary
Great #LAAC case at Zala County Hospital with Dr. Tamás TAHIN and Team.
Recently WATCHMAN FLX Device received FDA approvalfor DAPT labeling. With the approval of immediate DAPT-use post-implant, only the WATCHMAN FLX™ Implant provides you with flexibility to choose the ideal drug regimen that is best for your patient with clinical outcomes that support…
Dr. Gábor DURAY and Team performed a great left atrial appendage closure procedure at Military Hospital this week. Watchman FLX has a robust clinical evidence background: The SURPASS analysis of the NCDR-LAAO Registry™ has data of 16.000+ patients to date and confirms the best-in-class safety profile of Watchman FLX.
Want to learn more? https://www.watchman.com/en-us-implanter/clinical-evidence/surpass.html
#LAAC…
Great cases at Military Hospital with Dr. Gábor Duray, Dr. Balázs Polgár and Team performed LAAC procedures.
Results from FLXibility Post-Approval Study demonstrate WATCHMAN FLX has 88.2% complete closure (zero leak) at first follow-up in real-world, European WATCHMAN FLX patients. These new data reinforce 45-day complete closure rates seen in PINNACLE FLX (83%) and SURPASS…